Activity of cholinesterases in human whole blood measured with acetylthiocholine as substrate and ethopropazine as selective inhibitor of plasma butyrylcholinesterase

Arhiv za Higijenu Rada i Toksikologiju

Volumn 55, Issue 1, 2004, Pages 1-4

  Reiner, Elsa ^a   Bosak, Anita ^a   Simeon Rudolf, Vera ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

Author keywords

Acetylcholinesterase; Activity assays in whole blood; Protocol for measurement in whole blood

Indexed keywords

ACETYLTHIOCHOLINE; CHOLINESTERASE; PROFENAMINE;

ADULT; BLOOD; CONFERENCE PAPER; ENZYME ASSAY; ENZYME SUBSTRATE; ERYTHROCYTE; FEMALE; HEMOLYSIS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROLYSIS; MALE; NORMAL HUMAN; PLASMA; SPECTRAL SENSITIVITY;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; ENZYME TESTS; HUMANS; PHENOTHIAZINES; SPECTROPHOTOMETRY; SUBSTRATE SPECIFICITY;

EID: 1942505356     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Ellman GL, Courtney V, Andres RM, Featherstone A. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmcol 1961;7:88-95.
2. Reiner E, Simeon-Rudolf V. Cholinesterase activity assays: An overview of procedures suggested for human whole blood analysis. Chemical and Biological Medical Treatment Symposium (CBMTS) - Industry III "Second World Congress on Chemical, Biological and Radiological Terrorism". Dubrovnik, Croatia, 6-12 September 2003. Technical Programme, Abstract No. 70
3. Meuling WJA, Jongen MJM, van Hemmen JJ. An automated method for the determination of acetyl and pseudo cholinesterase in hemolyzed whole blood. Am J Ind Med 1992;22:231-41.
4. Worek F, Mast U, Kiderlen C, Diepold P, Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 1999;288:73-90.
5. Simeon V, Buntić A, Šurina B, Flegar-Meštrić Z. Cholinesterase phenotyping and distribution of activity in sera of 346 individuals. Acta Pharm Jugosl 1987;37: 107-14.
6. Simeon-Rudolf V, Evans RT. Interlaboratory study into the proficiency of attribution of human serum butyrylcholinesterase phenotypes: Reference values of activities and inhibitor numbers. Acta Pharm 2001;51: 289-96.
7. Reiner E, Šinko G, Škrinjarić-Špoljar M, Simeon-Rudolf V. Comparison of protocols for measuring activities of human blood cholinesterases by the Ellman method. Arh hig rada toksikol 2000;51:13-8.
8. Simeon-Rudolf V, Šinko G, Štuglin A, Reiner E. Inhibition of human blood acetylcholinesterase and butyrylcholinesterase by ethopropazine. Croat Chem Acta 2001;74:173-82.
9. Eyer P, Worek F, Kiderlen D, Šinko G, Štuglin A, Simeon-Rudolf V, Reiner E. Molar absorption coefficients for the reduced Ellman reagent: Reassessment. Anal Biochem 2003;312;224-7.
10. Augustinsson KB, Erikson H, Faijersson Y. A new approach to determine cholinesterase activities in samples of whole blood. Clin Chim Acta 1978;89: 239-52.
11. Radić Z, Pickering NA, Vellom DC, Camp S, Taylor P. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemisty 1993;32:12074-84.
12. Whittaker M. Cholinesterase. In: Beckman L, editor. Monograph in Human Genetics. Basel: Karger AG; 1986. vol. 11, pp 1-132.
13. Evans RT. Cholinesterase phenotyping: Clinical aspects and laboratory application. CRC Critical Reviews in Clinical Laboratory Sciences 1986;23;35-64.